Phuong N. Huynh

Array ( [id] => 7261354 [patent_doc_number] => 20040241160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Vegfr-1 antibodies to treat breast cancer' [patent_app_type] => new [patent_app_number] => 10/483919 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6293 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241160.pdf [firstpage_image] =>[orig_patent_app_number] => 10483919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265315 [patent_doc_number] => 20040242851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Bispecific antibodies that bind to vegf receptors' [patent_app_type] => new [patent_app_number] => 10/482630 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13255 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242851.pdf [firstpage_image] =>[orig_patent_app_number] => 10482630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100802 [patent_doc_number] => 20070184064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Chimeric peptide immunogens' [patent_app_type] => utility [patent_app_number] => 10/886038 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5259 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184064.pdf [firstpage_image] =>[orig_patent_app_number] => 10886038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159417 [patent_doc_number] => 20070172461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Polyepitope vaccines' [patent_app_type] => utility [patent_app_number] => 10/884183 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6587 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172461.pdf [firstpage_image] =>[orig_patent_app_number] => 10884183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116654 [patent_doc_number] => 20050069955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/880922 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29098 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069955.pdf [firstpage_image] =>[orig_patent_app_number] => 10880922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7193069 [patent_doc_number] => 20050163782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Modified binding molecules comprising connecting peptides' [patent_app_type] => utility [patent_app_number] => 10/880028 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 50190 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163782.pdf [firstpage_image] =>[orig_patent_app_number] => 10880028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 130775 [patent_doc_number] => 07700097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Purification and preferential synthesis of binding molecules' [patent_app_type] => utility [patent_app_number] => 10/880320 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 47 [patent_no_of_words] => 43461 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700097.pdf [firstpage_image] =>[orig_patent_app_number] => 10880320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127343 [patent_doc_number] => 20050059087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/877774 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 46933 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059087.pdf [firstpage_image] =>[orig_patent_app_number] => 10877774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 203994 [patent_doc_number] => 07628986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/877773 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 91 [patent_no_of_words] => 50020 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/628/07628986.pdf [firstpage_image] =>[orig_patent_app_number] => 10877773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7371994 [patent_doc_number] => 20040219149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Methods for the modulation of il-13' [patent_app_type] => new [patent_app_number] => 10/479870 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11445 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219149.pdf [firstpage_image] =>[orig_patent_app_number] => 10479870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088537 [patent_doc_number] => 20050008649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Chimeric molecules and methods of use' [patent_app_type] => utility [patent_app_number] => 10/858980 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 31203 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008649.pdf [firstpage_image] =>[orig_patent_app_number] => 10858980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7294987 [patent_doc_number] => 20040213790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'VEGF-related protein' [patent_app_type] => new [patent_app_number] => 10/859737 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26122 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213790.pdf [firstpage_image] =>[orig_patent_app_number] => 10859737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276639 [patent_doc_number] => 20040236090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Methods and materials relating to fibulin like polypeptides and polynucleotides' [patent_app_type] => new [patent_app_number] => 10/471346 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 47935 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20040236090.pdf [firstpage_image] =>[orig_patent_app_number] => 10471346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7372097 [patent_doc_number] => 20040219163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2' [patent_app_type] => new [patent_app_number] => 10/491761 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 35700 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219163.pdf [firstpage_image] =>[orig_patent_app_number] => 10491761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982766 [patent_doc_number] => 20050152836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/850941 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 38493 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152836.pdf [firstpage_image] =>[orig_patent_app_number] => 10850941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7326915 [patent_doc_number] => 20040253236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Glycoprotein VI and uses thereof' [patent_app_type] => new [patent_app_number] => 10/850034 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 72810 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253236.pdf [firstpage_image] =>[orig_patent_app_number] => 10850034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856388 [patent_doc_number] => 07374762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Drug conjugate composition' [patent_app_type] => utility [patent_app_number] => 10/846129 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11055 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/374/07374762.pdf [firstpage_image] =>[orig_patent_app_number] => 10846129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243196 [patent_doc_number] => 07588930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Compositions and methods for enhancing the immunogenicity of antigens' [patent_app_type] => utility [patent_app_number] => 10/835662 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21166 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/588/07588930.pdf [firstpage_image] =>[orig_patent_app_number] => 10835662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171802 [patent_doc_number] => 20070072234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Protein capable of binding plasticizer' [patent_app_type] => utility [patent_app_number] => 10/553305 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12829 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072234.pdf [firstpage_image] =>[orig_patent_app_number] => 10553305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7261416 [patent_doc_number] => 20040241171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Leukocyte inactivation module' [patent_app_type] => new [patent_app_number] => 10/489831 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1251 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241171.pdf [firstpage_image] =>[orig_patent_app_number] => 10489831 [rel_patent_id] =>[rel_patent_doc_number] =>)